MedTrace Logo

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

NCT02448576 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2017-06-01

No results posted yet for this study

Summary

The purpose of this study is to compare whether prophylactic cranial irradiation in patients with advanced triple negative breast cancer who had a response to first line chemotherapy could prolong brain-metastasis free survival.

Conditions

Interventions

RADIATION

prophylactic cranial irradiation

Prophylactic cranial irradiation in patients with advanced triple negative breast cancer who had a response to first line chemotherapy

Sponsors & Collaborators

  • wang shusen

    lead OTHER

Principal Investigators

  • Shusen Wang · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-31
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448576 on ClinicalTrials.gov